{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:15:49Z","timestamp":1722730549911},"reference-count":24,"publisher":"Japan Atherosclerosis Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.5551\/jat.64448","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T22:11:21Z","timestamp":1707862281000},"page":"1179-1193","source":"Crossref","is-referenced-by-count":0,"title":["Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan"],"prefix":"10.5551","volume":"31","author":[{"given":"Lubna","family":"Sato","sequence":"first","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"},{"name":"Department of Emergency and Critical Care Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"},{"name":"AMR Clinical Reference Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kakumoto","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"},{"name":"AMR Clinical Reference Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomiteru","family":"Togano","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishikane","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"},{"name":"AMR Clinical Reference Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumasa","family":"Okumura","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Yamada","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Inada","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hojo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Takasaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Critical Care, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Critical Care, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Teruya","sequence":"additional","affiliation":[{"name":"AIDS Clinical Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"},{"name":"AMR Clinical Reference Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Iseki","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"},{"name":"AMR Clinical Reference Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Iba T, Levy JH, Levi M, Connors JM, and Thachil J: Coagulopathy of Coronavirus Disease 2019. Crit Care Med, 2020; 48: 1358-1364","DOI":"10.1097\/CCM.0000000000004458"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, and Jonigk D: Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med, 2020; 383: 120-128","DOI":"10.1056\/NEJMoa2015432"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, and Berger JS: Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA, 2020; 324: 799-801","DOI":"10.1001\/jama.2020.13372"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Di Minno A, Ambrosino P, Calcaterra I, and Di Minno MND: COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies. Semin Thromb Hemost, 2020; 46: 763-771","DOI":"10.1055\/s-0040-1715456"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, and Di Nisio M: Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb Res, 2020; 196: 67-74","DOI":"10.1016\/j.thromres.2020.08.020"},{"key":"6","unstructured":"6) Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF, Kornblith LZ, Kahn SR, Marshall JC, Kim KS, Houston BL, Derde LPG, Cushman M, Tritschler T, Angus DC, Godoy LC, McQuilten Z, Kirwan BA, Farkouh ME, Brooks MM, Lewis RJ, Berry LR, Lorenzi E, Gordon AC, Ahuja T, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Contreras A, Costantini TW, de Brouwer S, Detry MA, Duggal A, D\u017eav\u00edk V, Effron MB, Eng HF, Escobedo J, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Froess JD, Fu Z, Galanaud JP, Galen BT, Gandotra S, Girard TD, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Haniffa R, Hegde SM, Hendrickson CM, Higgins AM, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Huang DT, Hudock K, Hunt BJ, Husain M, Hyzy RC, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski A, King AJ, Knudson MM, Kornblith AE, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Gallego Lima F, Linstrum K, Litton E, Lopez-Sendon J, Lother SA, Marten N, Saud Marinez A, Martinez M, Mateos Garcia E, Mavromichalis S, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nicolau JC, Nunez-Garcia B, Park JJ, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, Pompilio M, Quigley JG, Rosenson RS, Rost NS, Rowan K, Santos FO, Santos M, Santos MO, Satterwhite L, Saunders CT, Schreiber J, Schutgens REG, Seymour CW, Siegal DM, Silva DG, Jr., Singhal AB, Slutsky AS, Solvason D, Stanworth SJ, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Widmer RJ, Wilson JG, Yuriditsky E, Zhong Y, Berry SM, McArthur CJ, Neal MD, Hochman JS, Webb SA, and Zarychanski R: Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med, 2021; 385: 777-789"},{"key":"7","unstructured":"7) Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR, Turgeon AF, Escobedo J, Huang DT, Bradbury CA, Houston BL, Kornblith LZ, Kumar A, Kahn SR, Cushman M, McQuilten Z, Slutsky AS, Kim KS, Gordon AC, Kirwan BA, Brooks MM, Higgins AM, Lewis RJ, Lorenzi E, Berry SM, Berry LR, Aday AW, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Costantini TW, de Brouwer S, Derde LPG, Detry MA, Duggal A, D\u017eav\u00edk V, Effron MB, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Galanaud JP, Galen BT, Gandotra S, Garc\u00eda-Madrona S, Girard TD, Godoy LC, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Hamburg NM, Haniffa R, Hanna G, Hanna N, Hegde SM, Hendrickson CM, Hite RD, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Hudock K, Hunt BJ, Husain M, Hyzy RC, Iyer VN, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski AL, King AJ, Knudson MM, Kornblith AE, Krishnan V, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Lima FG, Linstrum K, Litton E, Lopez-Sendon J, Lopez-Sendon Moreno JL, Lother SA, Malhotra S, Marcos M, Saud Marinez A, Marshall JC, Marten N, Matthay MA, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Moore SC, Morillo Guerrero R, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nunez-Garcia B, Pandey A, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, P\u00e9rez Gonz\u00e1lez YS, Pompilio M, Prekker ME, Quigley JG, Rost NS, Rowan K, Santos FO, Santos M, Olombrada Santos M, Satterwhite L, Saunders CT, Schutgens REG, Seymour CW, Siegal DM, Silva DG, Jr., Shankar-Hari M, Sheehan JP, Singhal AB, Solvason D, Stanworth SJ, Tritschler T, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Wells BJ, Widmer RJ, Wilson JG, Yuriditsky E, Zampieri FG, Angus DC, McArthur CJ, Webb SA, Farkouh ME, Hochman JS, and Zarychanski R: Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med, 2021; 385: 790-802"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lemos ACB, do Esp\u00edrito Santo DA, Salvetti MC, Gilio RN, Agra LB, Pazin-Filho A, and Miranda CH: Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID). Thromb Res, 2020; 196: 359-366","DOI":"10.1016\/j.thromres.2020.09.026"},{"key":"9","unstructured":"9) Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, and Bikdeli B: Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA, 2021; 325: 1620-1630"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, \u00c1inle FN, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci LA, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, and J\u00fcni P: Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ, 2021; 375: n2400","DOI":"10.1136\/bmj.n2400"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Alikhan R, Bedenis R, and Cohen AT: Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev, 2014; 2014: Cd003747","DOI":"10.1002\/14651858.CD003747.pub4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Horiuchi H, Morishita E, Urano T, and Yokoyama K: COVID-19-Related Thrombosis in Japan: Final Report of a Questionnaire-Based Survey in 2020. J Atheroscler Thromb, 2021; 28: 406-416","DOI":"10.5551\/jat.RPT001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sato R, Ishikane M, Kinoshita N, Suzuki T, Nakamoto T, Hayakawa K, Bekki N, Hara H, and Ohmagari N: A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan. Glob Health Med, 2020; 2: 190-192","DOI":"10.35772\/ghm.2020.01044"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, and Conde JG: Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform, 2009; 42: 377-381","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, and White H: Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation, 2011; 123: 2736-2747","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Katsoularis I, Fonseca-Rodr\u00edguez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, Lindmark K, and Fors Connolly AM: Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ, 2022; 377: e069590","DOI":"10.1136\/bmj-2021-069590"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Feinbloom D, Freed JA, Carbo A, Jung Y, Adra M, and Herzig SJ: Incidence and risk factors for PTT prolongation in patients receiving low-dose unfractionated heparin thromboprophylaxis. J Thromb Thrombolysis, 2021; 52: 331-337","DOI":"10.1007\/s11239-020-02294-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Campbell NR, Hull RD, Brant R, Hogan DB, Pineo GF, and Raskob GE: Aging and heparin-related bleeding. Arch Intern Med, 1996; 156: 857-860","DOI":"10.1001\/archinte.156.8.857"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kanda Y: Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant, 2013; 48: 452-458","DOI":"10.1038\/bmt.2012.244"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Zhu W, He W, Guo L, Wang X, and Hong K: The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis. Clin Cardiol, 2015; 38: 555-561","DOI":"10.1002\/clc.22435"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Vedovati MC, Mancuso A, Pierpaoli L, Paliani U, Conti S, Ascani A, Galeotti G, Di Filippo F, Caponi C, Agnelli G, and Becattini C: Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study. Int J Cardiol, 2020; 301: 167-172","DOI":"10.1016\/j.ijcard.2019.11.105"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) O\u2019Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, Pencina MJ, Piccini JP, and Peterson ED: The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J, 2015; 36: 3258-3264","DOI":"10.1093\/eurheartj\/ehv476"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Cheng S, Morrow DA, Sloan S, Antman EM, and Sabatine MS: Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Circulation, 2009; 119: 1195-1202","DOI":"10.1161\/CIRCULATIONAHA.108.814996"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shimada YJ, Nakra NC, Fox JT, and Kanei Y: Relation of race (Asian, African-American, European-American, and Hispanic) to activated clotting time after weight-adjusted bolus of heparin during percutaneous coronary intervention. Am J Cardiol, 2010; 105: 629-632","DOI":"10.1016\/j.amjcard.2009.10.043"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/8\/31_64448\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:34:10Z","timestamp":1722659650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/8\/31_64448\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64448","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"article-number":"64448"}}